Chemours (CC) Misses Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- AI stocks lift Wall St as oil falls, Treasury yields decline
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
- Novo Nordisk shares drop as investor event disappoints
The Chemours Company Reports Fourth Quarter and Full Year 2015 Results
February 23, 2016 5:00 PM ESTWILMINGTON, Del., Feb. 23, 2016 /PRNewswire/ --
Fourth Quarter 2015 Highlights
Net sales of $1.4 billion Adjusted EBITDA of $132 million Free cash flow of $175 million led by working capital release of ~$399 million Adjusted Net Income of $5 million, or $0.03 per diluted share Net loss of $86 million, or $0.48 per diluted share, after restructuring costs of $88 million and interest expense of $53 millionOther Highlights
Announced $140 million Aniline sale to The Dow Chemical Company Reduced costs by $100 million in second half of 2015 through transformation initiatives Reached... More